These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12906952)

  • 21. [Quality of life suffers much in constipation. Plea for an intelligent pain therapy].
    MMW Fortschr Med; 2006 Aug; 148(35-36):55. PubMed ID: 16995370
    [No Abstract]   [Full Text] [Related]  

  • 22. A Clinical Study on Administration of Opioid Antagonists in Terminal Cancer Patients: 7 Patients Receiving Opioid Antagonists Following Opioids among 2443 Terminal Cancer Patients Receiving Opioids.
    Uekuzu Y; Higashiguchi T; Futamura A; Ito A; Mori N; Murai M; Ohara H; Awa H; Chihara T
    Biol Pharm Bull; 2017 Mar; 40(3):278-283. PubMed ID: 27980244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tolerated opioid therapy with oxycodone/naloxone. Better quality of life for osteoporosis patients].
    MMW Fortschr Med; 2009 Apr; 151(18):27. PubMed ID: 19769067
    [No Abstract]   [Full Text] [Related]  

  • 24. Intravenous bolus of ultra-low-dose naloxone added to morphine does not enhance analgesia in emergency department patients.
    Bijur PE; Schechter C; Esses D; Chang AK; Gallagher EJ
    J Pain; 2006 Feb; 7(2):75-81. PubMed ID: 16459272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence.
    Med Lett Drugs Ther; 2013 Oct; 55(1427):83. PubMed ID: 24129113
    [No Abstract]   [Full Text] [Related]  

  • 26. PRODUCT: Embeda 20mg/0.8mg.
    Physician Assistant's Prescribing Reference
    JAAPA; 2009 Nov; 22(11):12. PubMed ID: 19999169
    [No Abstract]   [Full Text] [Related]  

  • 27. [Modern pain therapy with dual advantage. Strong analgesia and superior tolerance].
    MMW Fortschr Med; 2009 Apr; 151(18):26. PubMed ID: 19769066
    [No Abstract]   [Full Text] [Related]  

  • 28. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.
    Meissner W; Leyendecker P; Mueller-Lissner S; Nadstawek J; Hopp M; Ruckes C; Wirz S; Fleischer W; Reimer K
    Eur J Pain; 2009 Jan; 13(1):56-64. PubMed ID: 18762438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effectiveness and tolerability of opioids for non-cancer pain].
    Freye R
    Med Monatsschr Pharm; 2015 Mar; 38(3):112-3. PubMed ID: 26364401
    [No Abstract]   [Full Text] [Related]  

  • 30. The attractiveness of opposites: agonists and antagonists.
    O'Brien T
    J Pain Palliat Care Pharmacother; 2015 Mar; 29(1):67-9. PubMed ID: 25643224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A small-dose naloxone infusion alleviates nausea and sedation without impacting analgesia via intravenous tramadol.
    Jia DL; Ni C; Xu T; Zhang LP; Guo XY
    Chin Med J (Engl); 2010 Jul; 123(13):1695-8. PubMed ID: 20819631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Formulation of Sustained Release Naloxone Can Reverse Opioid Induced Constipation Without Compromising the Desired Opioid Effects.
    Sanders M; Jones S; Löwenstein O; Jansen JP; Miles H; Simpson K
    Pain Med; 2015 Aug; 16(8):1540-50. PubMed ID: 26110375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Finding an optimal dose: considerations in accurate opioid dispensing.
    Dunn EB; Wolfe JJ
    Vet Hum Toxicol; 2000 Feb; 42(1):36-8. PubMed ID: 10670085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiological effects of blocking and stimulating the opioid system in patients with unexplained heart palpitations.
    Oldroyd KG
    Clin Cardiol; 1992 Nov; 15(11):872-3. PubMed ID: 10969635
    [No Abstract]   [Full Text] [Related]  

  • 35. Low-dose naloxone infusion for the treatment of intractable nausea and vomiting after intrathecal morphine in a parturient.
    Sposito JA; Habib AS
    Int J Obstet Anesth; 2010 Jan; 19(1):119-21. PubMed ID: 19945849
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnostic and therapeutic value of naloxone after intoxication with tramadol in a young girl.
    Grosek S; Mozina M; Grabnar I; Primozic J
    Pediatr Int; 2009 Dec; 51(6):842-3. PubMed ID: 20158629
    [No Abstract]   [Full Text] [Related]  

  • 37. Modest opioid withdrawal suppression efficacy of oral tramadol in humans.
    Lofwall MR; Walsh SL; Bigelow GE; Strain EC
    Psychopharmacology (Berl); 2007 Oct; 194(3):381-93. PubMed ID: 17605004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A year of chronic pain with Targin--experience from daily practice. Interview with Dr. Patricia Fehlmann].
    Fehlmann P
    Rev Med Suisse; 2011 Jun; 7(301):preceding 1414. PubMed ID: 21815498
    [No Abstract]   [Full Text] [Related]  

  • 39. Pain analysis in prediction of treatment outcome.
    Arnér S
    Acta Anaesthesiol Scand Suppl; 1998; 113():24-8. PubMed ID: 9932116
    [No Abstract]   [Full Text] [Related]  

  • 40. Distribution of naloxone for overdose prevention to chronic pain patients.
    Coe MA; Walsh SL
    Prev Med; 2015 Nov; 80():41-3. PubMed ID: 26024850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.